1
|
Güven CM, Uysal D. In-bag abdominal manual morcellation versus contained power morcellation in laparoscopic myomectomy: a comparison of surgical outcomes and costs. BMC Surg 2023; 23:106. [PMID: 37118798 PMCID: PMC10148462 DOI: 10.1186/s12893-023-02007-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 04/13/2023] [Indexed: 04/30/2023] Open
Abstract
BACKGROUND To compare the surgical outcomes and costs of in-bag abdominal manual morcellation (AMM) and contained power morcellation (PM) in laparoscopic myomectomy. METHODS A total of 61 patients were divided into two groups based on their myomectomy specimen extraction methods: AMM group (n = 33) and electromechanical contained PM group (n = 28). The surgical outcomes and cost were compared between groups. During AMM, a glove bag (in 27 patients) and an endo bag were used (in 6 patients) according to the myoma size. RESULTS Morcellation time (18 ± 9.2 min vs. 37.4 ± 14.1 min) and total operation time (100 ± 24.3 min vs. 127 ± 33.1 min) were significantly lower in the AMM group compared to those in the PM group. Other surgical outcomes, which were similar between groups, included delta hemoglobin, length of hospital stay and VAS score at 12 and 24 h postoperatively. There were no per- or postoperative complications in both group with no conversion to laparotomy. One patient was transfused with two units of erythrocyte suspension postoperatively in the PM group. Sarcoma was not diagnosed in any of the cases in both group. CONCLUSION The in-bag AMM or contained PM for specimen extraction resulted in similar outcomes in terms of delta hemoglobin, postoperative pain intensity (VAS score at 12 and 24 h postoperatively), the need for additional analgesia, and the length of hospital stay; however, total operation time and morcellation time were significantly shorter in the AMM group, indicating a prominent advantage. Significant cost-effectiveness is also a critical advantage of in-bag AMM compared to containing PM.
Collapse
Affiliation(s)
- Cenk Mustafa Güven
- Department of Obstetrics and Gynecology, Izmir Private Can Hospital, İzmir, Turkey.
| | - Dilek Uysal
- Department of Obstetrics and Gynecology, Atatürk Training and Research Hospital, University of Katip Çelebi, İzmir, Turkey
| |
Collapse
|
2
|
Herman A, Duraiswamy N, Nandy P, Myers MR, Price V, Gibeily G, Hariharan P. In Vitro Leakage Testing of Tissue Containment Bags When Subjected to Power Morcellation Forces. J Minim Invasive Gynecol 2019; 27:655-664. [PMID: 31125722 DOI: 10.1016/j.jmig.2019.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Revised: 04/15/2019] [Accepted: 05/11/2019] [Indexed: 10/26/2022]
Abstract
STUDY OBJECTIVE To determine the ability of tissue containment systems to prevent leakage of cancer cell surrogates when subjected to forces encountered during power morcellation procedures. DESIGN In vitro study. SETTING Medical device research laboratory. INTERVENTIONS Samples from 7 different legally marketed tissue containment bags (1 of which is indicated for power morcellation) were subjected to dye and bacteriophage penetration tests at pressures ranging from 0.5 to 50 times the insufflation pressure. The minimum pressure required to cause bag leakage was measured. Subsequently, the morcellation leakage safety factor for each bag was determined as the ratio of the minimum leakage pressure of the bag to the total pressure contributed from insufflation pressure and mechanical forces acting during the power morcellation procedure. MEASUREMENT AND MAIN RESULTS The leakage performance of the bags varied markedly from brand to brand. No correlation was found between leakage pressure and the bag material or the total bag thickness. The leakage pressures ranged from 26 mmHg to >1293 mmHg for the 7 bags, and safety factors ranged from 1 to 50 when only the insufflation pressure was considered. However, if the morcellation forces were included in the calculation, the safety factor dropped by 6-fold for all brands and dropped below 1, indicating likelihood of leakage, for 2 of the 7 brands. CONCLUSION This study provides a mechanism for more realistically simulating the conditions experienced by containment bags during morcellation and quantifying the level of safety provided by the bags.
Collapse
Affiliation(s)
- Alexander Herman
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - Nandini Duraiswamy
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - Poulomi Nandy
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - Matthew R Myers
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - Veronica Price
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - George Gibeily
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)
| | - Prasanna Hariharan
- Division of Applied Mechanics, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (all authors), and Office of Product Evaluation and Quality, Center for Devices and Radiological Health, Food and Drug Administration (Ms. Price, Drs. Gibeily and Nandy)..
| |
Collapse
|